Fourth quarter 2024 net loss was approximately $4.9 million, or $0.20 per common share, a 45% improvement compared to approximately $8.9 million, or $0.42 per common share, in the three months ended ...

Peto’s paradox is that bigger, longer-lived species should have higher cancer prevalence, yet they don’t seem to. Back in ...

Bill Faulkner had long approached prostate cancer testing with skepticism. For almost a decade, the 73-year-old had avoided ...

Researchers at Keck Medicine of USC are part of a national, multisite clinical trial to evaluate a minimally invasive water ...

The annual Cancer Survivors and Caregivers Conference is an event that aims to help people who have been affected by cancer. ...

Researchers at the University of Iowa say the tiny tardigrade, which is found all over our planet, can protect human skin and ...

Edamame is a healthy source of protein and fiber. It’s mostly imported from Asia, but harvests in the United States are ...

PORTSMOUTH — Help the American Heart Association in New Hampshire fund lifesaving research and education by attending the ...

The new findings could have far-reaching implications, especially since 90% of cancer deaths occur when cancer spreads ...

A phase 1/2 trial is evaluating HLD-0915, a novel oral therapy, for metastatic castration-resistant prostate cancer in up to ...

Dr. Park shares the three biggest takeaways, in his opinion, to have come out of the ASCO GU Symposium, highlighting studies ...

One test could have prevented terminal prostate cancer, says patient - Research has shown that the use of the PSA test varies ...